SIRIO(SZ:300791)2022-04-13 16:00Financial Performance - The company reported a net profit of 158.59 million yuan, accounting for 6.23% of the total equity attributable to shareholders at the end of the reporting period[14]. - The company's operating revenue for 2021 was CNY 2,368,947,616.87, representing a 14.62% increase compared to CNY 2,066,817,765.70 in 2020[34]. - The net profit attributable to shareholders for 2021 was CNY 231,834,489.00, a decrease of 9.92% from CNY 257,366,015.36 in the previous year[34]. - The net profit after deducting non-recurring gains and losses was CNY 209,799,088.33, down 5.61% from CNY 222,278,606.64 in 2020[34]. - The company's total assets increased by 44.17% to CNY 3,820,110,170.19 at the end of 2021, compared to CNY 2,649,636,693.93 at the end of 2020[34]. - The basic earnings per share for 2021 was CNY 1.29, a decrease of 9.79% from CNY 1.43 in 2020[34]. - The weighted average return on net assets was 9.77% in 2021, down from 12.48% in 2020[34]. - The net cash flow from operating activities for 2021 was CNY 341,377,365.21, an increase of 6.82% from CNY 319,573,018.84 in 2020[34]. - The total equity attributable to shareholders increased by 16.59% to CNY 2,544,779,706.22 at the end of 2021, compared to CNY 2,182,687,275.64 at the end of 2020[34]. - The company achieved operating revenue of 2.369 billion yuan in 2021, representing a year-on-year growth of 14.62%[60]. Dividend Distribution - The company plans to distribute a cash dividend of 4 yuan per 10 shares to all shareholders, based on a total of 180,169,870 shares[14]. Quality Management and Compliance - The company has a quality management team with over 20 years of experience in the nutrition and health food sector, ensuring product safety and compliance with evolving standards[8]. - The company emphasizes the importance of quality management across all levels of its operations to prevent potential product safety risks[8]. - The company is committed to continuous improvement in its internal control standards to align with new policies and regulations in the nutrition and health food industry[11]. - The company has a recognized inspection center equipped with advanced testing equipment to enhance its quality control capabilities[8]. - The company is actively involved in the formulation and revision of industry regulations to mitigate operational risks associated with regulatory changes[11]. Product Development and Innovation - The company is focusing on product innovation and market-driven management to maintain its competitive edge amid increasing industry competition[12]. - The company aims to become an innovation leader in the nutrition and health sector, with a vision to be the first choice for customers[60]. - The company has over 4,000 mature nutrition and health food product formulas, addressing diverse health needs across different age groups[59]. - The company has a diverse product development strategy, including self-developed products and customized products based on client needs[72]. - The company has introduced multiple new products, including various vitamin and mineral supplements, enhancing its product portfolio[102]. Market Presence and Sales - Domestic sales revenue reached 1.458 billion yuan, growing by 14.06% year-on-year, while overseas sales revenue was 911 million yuan, up 15.60% year-on-year[60]. - The company operates in the nutrition and health food sector, focusing on contract development and manufacturing (CDMO) for B-end clients[53]. - The company has established production bases and marketing centers in China, Germany, and the United States, enhancing its global market presence[53]. - The company sold 663.51 million units of its products, marking a year-on-year increase of 16.88%[110]. - The soft candy segment experienced significant growth, with revenue increasing by 44.22% to approximately CNY 471.94 million[107]. Research and Development - The company invested CNY 83.19 million in R&D during the first half of 2021, representing a year-on-year increase of 28.56%[61]. - The company submitted 35 invention patent applications during the reporting period, reflecting its commitment to continuous innovation[61]. - The number of R&D personnel increased by 18.22% to 318, with R&D personnel accounting for 12.95% of the total workforce[126]. - The company has established a comprehensive R&D center recognized as the "Guangdong Province International Engineering Technology Research Center for Nutritional Health Food" and "Guangdong Province Enterprise Technology Center"[82]. Operational Efficiency - The company has established a digital factory project to enhance operational efficiency through lean operations and supply chain optimization[66]. - The company aims to establish an excellent supply chain to reduce costs and increase efficiency, integrating resources across the entire process from design to service[172]. - The company has implemented measures to manage foreign exchange risks due to significant export activities, particularly in the Americas and Europe[13]. Future Outlook - Future outlook indicates continued growth in revenue driven by new product development and market expansion strategies[103]. - The company plans to enhance its research and development efforts to introduce more health-focused products in response to market demand[103]. - The company aims to maintain a strong position in the health supplement market by leveraging innovative technologies in product formulation[103]. - The company anticipates a shift in health consumption demographics towards younger groups, with an increase in preventive health needs and diversified product offerings[161]. Governance and Compliance - The company has established an independent, complete, and standardized financial accounting system and management system, allowing for independent financial decision-making[200]. - The board of directors consists of 7 members, including 3 independent directors, complying with legal and regulatory requirements[189]. - The company has a performance evaluation system linking employee income to work performance and company performance[192]. - The company actively respects and protects the legitimate rights and interests of stakeholders, promoting balanced interests among shareholders, employees, and society[191].